What's On

This session will give biotech founders a clear and practical understanding of what it really takes to list on the ASX: when it makes sense, what investors expect, and the obligations and challenges of becoming a listed company. Even if you’re currently VC-funded, it’s worth exploring whether an ASX listing could be a viable alternative or complementary funding pathway for your company.

Brought to you by Jumar Bioincubator and Medtech Actuator, this event will feature experienced biotech entrepreneurs as they share how early-stage biotech teams can position themselves for global opportunity from day one. Our speakers will draw on their own experience working across global biotech and medtech ecosystems, sharing practical approaches for identifying partners and tips to navigate cross-border collaboration.